| 0 (0%) | 10-24 16:03 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.91 | 1-year : | 2.39 |
| Resists | First : | 1.63 | Second : | 2.04 |
| Pivot price | 1.31  |
|||
| Supports | First : | 0.97 | Second : | 0.8 |
| MAs | MA(5) : | 1.07 |
MA(20) : | 1.3 |
| MA(100) : | 1.07 |
MA(250) : | 1.53 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 8.3 |
D(3) : | 7.4 |
| RSI | RSI(14): 47.3 |
|||
| 52-week | High : | 3.39 | Low : | 0.59 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ FFR ] has closed above bottom band by 33.5%. Bollinger Bands are 70.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 24 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.24 - 1.25 | 1.25 - 1.26 |
| Low: | 0.97 - 0.98 | 0.98 - 0.99 |
| Close: | 1.12 - 1.13 | 1.13 - 1.14 |
Fri, 23 Oct 2026
FF EAI Robotics Ecosystem Inc. Estimates – NASDAQ:FFR - TradingView
Fri, 23 Oct 2026
FFR-CT Software Gets FDA Clearance - www.dicardiology.com
Wed, 21 Oct 2026
FF EAI Robotics Ecosystem Inc. (FFR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wed, 21 Oct 2026
Elucid Scores FDA Clearance for FFR-IQ to Unify Plaque Biology and Hemodynamics - HIT Consultant
Wed, 21 Oct 2026
Elucid gets FDA clearance for plaque-informed FFR-CT software - AuntMinnie
Wed, 21 Oct 2026
FDA clears Elucid's new AI-enabled FFR-CT software - Cardiovascular Business
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 1.995e+007 (%) |
| Held by Institutions | 63.7 (%) |
| Shares Short | 117 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -134.4 % |
| Return on Equity (ttm) | -1 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 239.75 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -6.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 64.41 |
| Dividend | 0 |
| Forward Dividend | 826690 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|